NCT07756216

Brief Summary

The first permanent molars in children can sometimes develop a condition called molar-incisor hypomineralization (MIH), which affects the strength and quality of the tooth structure. These teeth are more prone to breakdown and tooth decay, which may lead to inflammation of the dental pulp (the living tissue inside the tooth). This study aims to evaluate the effectiveness of vital pulp therapy, a treatment designed to preserve the health of the pulp and maintain the tooth's function. The goal is to save the pulp tissue and reduce the need for more complex treatments such as root canal therapy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
35mo left

Started Dec 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Dec 2025Jul 2029

Study Start

First participant enrolled

December 21, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

1.5 years

First QC Date

August 5, 2026

Last Update Submit

August 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical and radiographic success after pulpotomy

    Clinical and radiographic success will be assessed based on the presence or absence of signs and symptoms of treatment failure at follow-up visits. Clinical success will be defined as the absence of spontaneous pain, tenderness to percussion or palpation, swelling, sinus tract, abnormal mobility, or other clinical signs of pulpal or periapical disease. For teeth undergoing partial pulpotomy, continued positive response to pulp sensibility testing will also be considered a criterion for clinical success. Radiographic success will be defined as the absence of new pathological findings, including periapical or furcal radiolucency, root resorption, or other radiographic evidence of treatment failure on follow-up imaging.

    6 and 12 months after treatment

Secondary Outcomes (1)

  • Postoperative pain after pulpotomy

    One week after pulpotomy

Other Outcomes (2)

  • Tooth survival

    12 months post pulpotomy

  • Patient satisfaction following pulpotomy treatment

    6 and 12 months after treatment

Study Arms (1)

MIH-Affected Permanent Molars Receiving Stepwise Pulpotomy Treatment

EXPERIMENTAL

MIH affected molars will receive a stepwise vital pulp therapy approach. Partial pulpotomy will be performed initially, and if adequate hemostasis cannot be achieved, the procedure will be converted to full pulpotomy. A calcium silicate-based pulp capping material and definitive restoration will be placed following the pulpotomy procedure. Participants will be followed clinically and radiographically for treatment outcomes.

Procedure: Step wise pulpotomy

Interventions

The stepwise vital pulp therapy approach include : partial pulpotomy will be performed initially, and if adequate hemostasis cannot be achieved, the procedure will be converted to full pulpotomy to the level of the root canal orifices.

MIH-Affected Permanent Molars Receiving Stepwise Pulpotomy Treatment

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The patient age \<14 years old
  • Non -contributory medical history
  • Molar tooth affected with MIH as per EAPD diagnostic criteria (17).
  • Deep caries extending\>= 2/3 of dentine or exposing the pulp on the radiograph
  • The tooth should give positive response to cold sensibility testing
  • Clinical diagnosis of reversible/irreversible pulpitis based on the symptoms and results of cold testing.
  • The tooth is restorable, probing pocket depth and mobility are within normal limits
  • No signs of pulpal necrosis including sinus tract or swelling

You may not qualify if:

  • Medically compromised patient.
  • Non-restorable tooth.
  • Signs of pulpal necrosis including sinus tract or swelling.
  • Uncooperative children who could not be treated under local anesthesia.
  • No enough bleeding after the pulpotomy procedure.
  • Inability to achieve hemostasis within 8 min after the pulpotomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordan university of science and Technology

Irbid, 3030, Jordan

Location

Related Links

MeSH Terms

Conditions

Molar Hypomineralization

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Nessrin Taha, DClinDent, PhD

    Jordan University of Science and Technology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All participants will receive the same stepwise vital pulp therapy protocol. Partial pulpotomy will be performed as the initial treatment approach. If adequate hemostasis cannot be achieved following partial pulpotomy, the procedure will be converted to full pulpotomy. The final treatment provided will therefore depend on the pulpal response during the procedure. Participants will be followed prospectively to evaluate clinical and radiographic outcomes after treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professsor

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 10, 2026

Study Start

December 21, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2029

Last Updated

August 10, 2026

Record last verified: 2026-08

Locations